During the inaugural event of expanded Process and Analytical Development Laboratories at Lonza Houston, leaders and innovators from the industry look the stage for a panel discussion around process development and commercial readiness for cell & gene therapy manufacturing.
Anthony Davies, Chair, CEO, Dark Horse Consulting
Brian Price, co-founder, Neucore Bio
Heikki Jouttijarvi, SVP & Head of Tech Ops, Adverum Biotechnologies, Inc.
Maxwell De Long, Director and Senior Principal, Individualized Medicines, Genentech
Behnam Ahmadian Baghbaderani, Global Head of CGT Process Development, Lonza